Atlas Trials

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT01225887 · COMPLETED

Trial details

NCT number
NCT01225887
Sponsor
Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Squamous Cell CarcinomaEndometrial Transitional Cell CarcinomaEndometrial Undifferentiated CarcinomaMalignant Uterine Corpus Mixed Epithelial and Mesenchymal NeoplasmRecurrent Uterine Corpus Carcinoma
Start date
2011-10-01
Primary completion
2016-01-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.